{"name":"RiboX Therapeutics Ltd.","slug":"ribox-therapeutics-ltd","ticker":"","exchange":"","domain":"ribox.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQUWM5TTF6eHU0UU05Y2VIM09BTHE2NzJDME5jaXlzWlkyR1BGd1c0ZlUxd3ZxMHZGNXFidUF3ZnJZX0VDVFAtRE5FQWRYY2RQeWwxc2Nnekp1VjJYVWRJaFVnemZmNlJxX1lHdHZnV09MVmM0empJZ3BJNVlRUnRwWGVJRWwtYzdmY3c?oc=5","date":"2025-04-04","type":"trial","source":"endpoints.news","summary":"Secretive Chinese startup begins first-ever clinical trial of circular RNA therapy - endpoints.news","headline":"Secretive Chinese startup begins first-ever clinical trial of circular RNA therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPTUhaZUEwT052VXQ0blNCS21KQU0yUEEtWXNmNlpnRUw4bWI1ZVp0cWF0X3liV0lRQVJZZ2U3SGk1OXE5Z0RsbThqUWZRNUtDNjdlTW45VGVyTThmMjh1YW1Hdi16bUFId0FQRzBjbFJKT0FSQVE3TnQyclhDd2dRV05DRFJjeGxnSXl4NGJlOUpUUGhCLUI0SVhFOGRwUDlMYjVPQS1YUmdLQThuQjZrY2ZUUzRTcGtTRXdUT3V2bjdWVzdBUFE?oc=5","date":"2024-11-03","type":"trial","source":"CGTLive®","summary":"RiboX's Circular RNA Therapy RXRG001 Cleared for Phase 1/2a Trial in Radiation-Induced Xerostomia and Hyposalivation - CGTLive®","headline":"RiboX's Circular RNA Therapy RXRG001 Cleared for Phase 1/2a Trial in Radiation-Induced Xerostomia and Hyposalivation - C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxOWTRGX0tqZDFhUEk4bUR0NHluLTdHMm9kVkxrUVNjbkZGRGw4RVFZZkh2YVQ1cEZ5VHZ0T3dSOGtVRzBTQmJDS2gydUJjVEhwdEtVbzFPYngxQ1FPa1hqN3AwVk9wUW1Ib0ltVDlyMDJZNF8tQXJmbG1uZy1ESXFRQXo5eU9iMVNadVlVXzZoclVubWUyVGZxMXdxcUVSQy1hcEx1eEpXT0o2WHRmZlBTb3BFbXUtVGkyQ0djanRhV3liTm1WMEFtcWlFWTJHbEhXQlV3T0pZSjctajFiSVhNLUczWDJNZU9xSFJpcTVYbw?oc=5","date":"2024-10-25","type":"regulatory","source":"BioPharma APAC","summary":"RiboX Therapeutics Secures FDA IND Clearance for First Circular RNA Therapy, Initiating Clinical Trials for RXRG001 - BioPharma APAC","headline":"RiboX Therapeutics Secures FDA IND Clearance for First Circular RNA Therapy, Initiating Clinical Trials for RXRG001","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOY09Oekk3dkNWM0NCbjZyMk5EVFZJaXdGYTdWdWdjUXVaWHZOcnhmWEhEeE1tZ2xaWHZ2QXdvNldydVVhZ2RHckthdmM1Y0NudmVsRDN6MFpwM2VRVE04TlNQMHNRRjFfYkpGY2xMNk45MjczV2RReGFZMkpmTU1yc1pmVlBEblF4UjBn?oc=5","date":"2023-03-21","type":"pipeline","source":"Global Venturing","summary":"Hu moves to BI Venture Fund investment director role - Global Venturing","headline":"Hu moves to BI Venture Fund investment director role","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}